CorAssist
Herzliya
About CorAssist
CorAssist is a clinical stage medical device company committed to developing innovative therapeutic products for treating Heart Failure with Preserved Ejection Fraction. The company's proprietary technology enables the first implantation of a device that directly improves cardiac diastolic function. CORolla®, is an elastic self-expanding internal spring-like device implanted inside the left ventricular, through a Transapical or percutaneous procedure. The device assists diastolic function by improving diastolic dynamics and filling performance, and does not require an external power source. ImCardia® , the company's first product, is an elastic self-expanding device that is attached to the external left ventricular surface, through a simple off pump procedure.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $10.1M
- Last round: Grant (Nov 2018)
- Website: corassist.com
- Phone: 972 9 955 4500
Industries & Categories
Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/corassist-2233476 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.